Possibia

439

Last Update Posted: 2018-01-18

Recruiting has ended

All Genders

accepted

18 Years-65 Years

72 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Drug Treatment for Alcoholics With Bipolar Disorder

The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in treating individuals with alcohol dependence and comorbid bipolar disorder.

The aim of this study is to test the mood stabilizer, anticonvulsant, sodium valproate in individuals with alcohol dependence and bipolar disorder, in a double-blind, placebo-controlled, and randomized trial of 6 months duration. All subjects are treated with treatment as usual, which include lithium carbonate and individual dual recovery counseling and are randomized to either sodium valproate or placebo.

Eligibility

Relevant conditions:

Alcoholism

Bipolar Disorder

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov